According to Cerevel Therapeutics's latest financial reports the company's total liabilities are $0.56 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.56 B | 14.69% |
2022-12-31 | $0.49 B | 350.66% |
2021-12-31 | $0.11 B | 81.37% |
2020-12-31 | $60.75 M | 41.34% |
2019-12-31 | $42.98 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Archer Daniels Midland (ADM)
ADM | $30.16 B | 5,196.43% | ๐บ๐ธ USA |
Campbell Soup CPB | $8.25 B | 1,349.38% | ๐บ๐ธ USA |
Dow DOW | $38.85 B | 6,722.72% | ๐บ๐ธ USA |
Dupont De Nemours DD | $13.82 B | 2,327.69% | ๐บ๐ธ USA |